PedAM

Pediatric Disease Annotations & Medicines

Disease	motor neuron disease
Phenotype	C0497327\|dementia
Sentences	11
PubMedID- 20500451	Ubiquitin-positive tau-negative intraneuronal inclusions in dementia with motor neuron disease: the 50th anniversary of japanese society of neuropathology.
PubMedID- 21029204	Semantic dementia with lower motor neuron disease showing ftld-tdp type 3 pathology (sensu mackenzie).
PubMedID- 22300873	The patients' clinical phenotype at presentation varied: nine patients had frontotemporal dementia with motor neuron disease, 19 had frontotemporal dementia alone, one had mixed semantic dementia with frontal features and three had progressive non-fluent aphasia.
PubMedID- 22051030	Right temporal variant frontotemporal dementia with motor neuron disease.
PubMedID- 24818133	Using pet-fdg, different patterns of hypometabolism have been observed when the motor neuron disease (mnd) coexists with frontotemporal dementia (ftd).
PubMedID- 23445572	We believe the results indicate a subgroup of motor neuron disease with dementia whose initial symptoms involve pseudobulbar palsy and dementia, and which shows rapid progression to mutism.
PubMedID- 22919484	As reports of patients with motor neuron disease (mnd) associated with dementia were published in increasing numbers [7–18] and the clinical features of frontotemporal dementia were better described including consensus criteria first published in 1998 [19, 20], it became clear that the dementia seen in als patients is best characterized as ftd [21, 22].
PubMedID- 20627585	Comment on "semantic dementia combined with motor neuron disease".
PubMedID- 21624986	Predicting survival in frontotemporal dementia with motor neuron disease.
PubMedID- 21298310	We described the cases of two patients with dementia associated with motor neuron disease, the former with frontotemporal dementia (ftd) and the latter with alzheimer's disease (ad), studied by the pittsburgh compound b-positron emission tomography (pib-pet).
PubMedID- 21569259	Our observations further support the concept that tdp-43 proteinopathies represent a spectrum of disorders, where preferential localization of pathogenetic inclusions and neuronal cell loss defines clinical phenotypes ranging from frontotemporal dementia with or without motor neuron disease, to corticobasal syndrome and to a progressive supranuclear palsy-like syndrome.

Page: 1